CR20210173A - Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen - Google Patents

Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen

Info

Publication number
CR20210173A
CR20210173A CR20210173A CR20210173A CR20210173A CR 20210173 A CR20210173 A CR 20210173A CR 20210173 A CR20210173 A CR 20210173A CR 20210173 A CR20210173 A CR 20210173A CR 20210173 A CR20210173 A CR 20210173A
Authority
CR
Costa Rica
Prior art keywords
pyrimidonyl
preparation
pharmaceutical compositions
compositions containing
new amino
Prior art date
Application number
CR20210173A
Other languages
English (en)
Inventor
Péter Spránitz
Olivier Geneste
András Kotschy
Csaba Wéber
Didier Demarles
Alba Macias
Lisa Ivanschitz
Tibor SOÓS
Attila Vasas
Balázs Molnár
Kristóf Hegedüs
Árpád Kiss
James Brooke Murray
Andrea Fiumana
Original Assignee
Vernalis R&D Ltd
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vernalis R&D Ltd, Servier Lab filed Critical Vernalis R&D Ltd
Publication of CR20210173A publication Critical patent/CR20210173A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Abstract

Compuestos de fórmula (I): en donde R1, R2, R3, R4, R5, n y Q son como se definen en la descripción. Medicamentos.
CR20210173A 2018-10-19 2019-10-18 Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen CR20210173A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18306377 2018-10-19
EP19305936 2019-07-12
PCT/EP2019/078318 WO2020079205A1 (en) 2018-10-19 2019-10-18 New amino-pyrimidonyl-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
CR20210173A true CR20210173A (es) 2021-05-11

Family

ID=68234009

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20210173A CR20210173A (es) 2018-10-19 2019-10-18 Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen

Country Status (24)

Country Link
US (1) US20210355106A1 (es)
EP (1) EP3866930A1 (es)
JP (1) JP2022505122A (es)
KR (1) KR20210081371A (es)
CN (1) CN113038990A (es)
AU (1) AU2019360391A1 (es)
BR (1) BR112021006714A2 (es)
CA (1) CA3116089A1 (es)
CL (1) CL2021000973A1 (es)
CO (1) CO2021004553A2 (es)
CR (1) CR20210173A (es)
DO (1) DOP2021000063A (es)
EC (1) ECSP21024078A (es)
IL (1) IL282218A (es)
JO (1) JOP20210063A1 (es)
MA (1) MA53900A (es)
MX (1) MX2021004379A (es)
NI (1) NI202100024A (es)
PE (1) PE20211649A1 (es)
PH (1) PH12021550788A1 (es)
SG (1) SG11202103279RA (es)
TW (1) TW202028188A (es)
UY (1) UY38423A (es)
WO (1) WO2020079205A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022007665A (es) 2019-12-20 2022-07-19 Bayer Ag Tiofenocarboxamidas sustituidas y sus derivados.
CN114507163A (zh) * 2020-11-16 2022-05-17 尚科生物医药（上海）有限公司 一种制备2-氟-5-甲氧基苯磺酰氯的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017277732B2 (en) * 2016-06-10 2021-06-17 Les Laboratoires Servier New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
FR3052452B1 (fr) * 2016-06-10 2018-06-22 Les Laboratoires Servier Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB201617758D0 (en) * 2016-10-20 2016-12-07 Almac Discovery Limited Pharmaceutical compounds

Also Published As

Publication number Publication date
CN113038990A (zh) 2021-06-25
CL2021000973A1 (es) 2021-11-19
EP3866930A1 (en) 2021-08-25
ECSP21024078A (es) 2021-05-31
KR20210081371A (ko) 2021-07-01
MA53900A (fr) 2022-01-26
JOP20210063A1 (ar) 2023-01-30
TW202028188A (zh) 2020-08-01
US20210355106A1 (en) 2021-11-18
NI202100024A (es) 2021-08-24
JP2022505122A (ja) 2022-01-14
WO2020079205A1 (en) 2020-04-23
IL282218A (en) 2021-05-31
PE20211649A1 (es) 2021-08-24
BR112021006714A2 (pt) 2021-07-27
CA3116089A1 (en) 2020-04-23
CO2021004553A2 (es) 2021-04-30
MX2021004379A (es) 2021-06-04
DOP2021000063A (es) 2021-08-31
UY38423A (es) 2021-02-26
PH12021550788A1 (en) 2021-10-18
AU2019360391A1 (en) 2021-05-13
SG11202103279RA (en) 2021-04-29

Similar Documents

Publication Publication Date Title
TN2018000395A1 (en) New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
TN2018000410A1 (en) New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
TN2017000521A1 (en) New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them
TN2017000524A1 (en) New bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them
TN2017000511A1 (en) New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them.
SA518392049B1 (ar) مشتقات أمونيوم جديدة، عملية لتحضيرها وتركيبات صيدلانية تحتوي عليها
EP4241772A3 (en) Process for the preparation of compounds useful for treating spinal muscular atrophy
MX2020009530A (es) Inhibidores de la o-glicoproteína-2-acetamido-2-desoxi-3-dglicopir anosidasa.
WO2019165043A3 (en) Indane-amines as pd-l1 antagonists
CR20210216A (es) Derivados de piridinil sulfonamida, composiciones farmacéuticas y usos de estos
MX2021004000A (es) Derivados de piperidina.
MX2022004451A (es) Heteroaril-bifenil-amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1.
CR20220014A (es) Derivados de 3,6-diamino-piridazin-3-ilo, composiciones farmacéuticas que los contienen y sus usos como agentes proapoptóticos
MX2022004450A (es) Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1.
PH12020550448A1 (en) Novel macrocyclic derivatives, process for preparing same and pharmaceutical compositions containing same
PH12021550788A1 (en) New amino-pyrimidonyl-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
PH12021550439A1 (en) O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
MX2020014327A (es) Nuevos derivados de amino-pirimidonilo un proceso para su preparacion y composiciones farmaceuticas que los contienen.
TN2018000175A1 (en) Indane derivatives as mglur7 modulators